Brief: Calliditas Therapeutics Q2 Oper Loss Widens To SEK 159.4 Mln

Calliditas Therapeutics AB

19/08/2021 06:10

Aug 19 (Reuters) - Calliditas Therapeutics AB  CALTX.ST :
    * Q2 OPERATING LOSS AMOUNTED TO SEK 159.4 MILLION AND SEK
66.6
MILLION FOR THREE MONTHS ENDED JUNE 30, 2021 AND 2020,
RESPECTIVELY.
    * Q2 NO NET SALES WERE RECOGNIZED FOR THREE MONTHS ENDED
JUNE 30,
2021 AND 2020, RESPECTIVELY.
    * Q2 LOSS BEFORE INCOME TAX AMOUNTED TO SEK 165.2 MILLION
AND SEK
61.3 MILLION FOR THREE MONTHS ENDED JUNE 30, 2021 AND 2020,
RESPECTIVELY.

Source text for Eikon:  ID:nWkr7TzR6x 
Further company coverage:  CALTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))